BELLUS Health Stock Price

-0.07 (-1.75%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
BELLUS Health Inc BLU NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.07 -1.75% 3.93 15:18:17
Open Price Low Price High Price Close Price Prev Close
4.01 3.795 4.08 4.00
Bid Price Ask Price Spread News
3.93 3.94 0.01 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
7,266 993,584 $ 3.90 $ 3,877,199 1,310,535 2.01 - 12.03
Last Trade Time Type Quantity Stock Price Currency
15:18:16 100 $ 3.93 USD

BELLUS Health Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 307.87M 78.34M 78.34M $ 27.39k $ - - -6.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

BELLUS Health News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BLU Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.424.423.333.792,040,3670.5114.91%
1 Month3.074.422.863.441,012,6940.8628.01%
3 Months2.464.422.253.111,654,7961.4759.76%
6 Months2.784.422.012.811,450,6591.1541.37%
1 Year8.9012.032.013.671,701,861-4.97-55.84%
3 Years7.1212.032.013.781,277,080-3.19-44.8%
5 Years7.1212.032.013.781,277,080-3.19-44.8%

BELLUS Health Description

BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with high unmet medical need, including BLU-5937, P2X3 antagonist that has the potential to be a best-in-class therapeutic for chronic cough. The company operates in one business segment namely, development of drug candidates for health solutions.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.